Delivery Order SPE2DB24D2018-SPE2DB25FWUQ7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,398.46 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 60 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder and binge eating disorder. The contract, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, utilizes firm fixed pricing and represents a non-competitive set-aside award. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,328.29 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 10 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder. The award, issued on August 15, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 18, 2025. This contract was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,583.20 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 70 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder and binge eating disorder. This competitive, firm fixed-price delivery order was awarded on September 15, 2025, with an ultimate completion date of September 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,052.14 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 60 mg, a prescription stimulant medication commonly used to treat attention-deficit/hyperactivity disorder. The contract is a firm fixed price delivery order with an ultimate completion date of June 20, 2025, and was competitively awarded without set-aside restrictions. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the performing...
- The Defense Logistics Agency awarded a $2,239.00 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 10 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder. The contract was competitively awarded without set-aside designation and is classified as a firm fixed price delivery order, with an ultimate completion date of August 25, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of...
- The Defense Logistics Agency awarded a delivery order valued at $1,831.88 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 20 mg, a prescription stimulant medication commonly used to treat attention-deficit/hyperactivity disorder. The award, issued on July 8, 2025, with an ultimate completion date of July 9, 2025, represents a firm fixed-price delivery order with no set-aside designation. This order was fulfilled from AmerisourceBergen's place of performance in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,884.04 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 70 mg, a prescription stimulant medication used in the treatment of attention deficit hyperactivity disorder. The contract was competitively awarded with no set-aside designation and employs firm fixed price terms, with an ultimate completion date of June 6, 2025. The award was issued to AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, which...
- The Defense Logistics Agency awarded a delivery order valued at $1,080.26 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 70 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder. Awarded on April 9, 2025, with an ultimate completion date of April 10, 2025, this firm fixed price delivery order represents a routine pharmaceutical supply transaction. The contract carries no set-aside designation and will be performed at...
- The Defense Logistics Agency awarded a $3,007.07 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 50 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder. The contract was awarded on July 18, 2025, with an ultimate completion date of July 21, 2025, under firm fixed pricing with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,634.42 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 10 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder. This competitively awarded, firm fixed-price delivery order was issued on August 26, 2025, with an ultimate completion date of August 27, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The...
- SPE2DB24D2018Indefinite Delivery Contract
- SPE2DB24D2018-SPE2DB25FWUQ7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,329.49 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 70 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder and binge eating disorder. Awarded on May 20, 2025, with an ultimate completion date of May 21, 2025, this firm fixed price delivery order represents a routine pharmaceutical supply transaction executed through a competitively awarded contract with no set-aside designation. The product will be supplied from AmerisourceBergen's operations in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a critical pharmaceutical prime vendor for the Defense Logistics Agency, AmerisourceBergen supplies a comprehensive range of medications and medical commodities to support military healthcare systems and veteran services. The company's IDC serves as a flexible procurement vehicle enabling deliveries of specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains to support global military medical operations and other federal healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 5/20/25 |